Answers are grounded in this paper and cite their sources.
SUCCESSFUL HORMONE THERAPY depends in a large measure upon three factors, a) a satisfactory hormone preparation of uniform potency, b) moderate cost of adequate therapy and c) a convenient and effective method of administering the hormone. Desoxycorticosterone acetate, a synthetic adrenal cortical hormone, has been employed successfully in the treatment of patients with severe adrenal cortical insufficiency (1). The crystalline hormone preparation ensures uniform potency and it is possible to maintain an effective concentration of hormone by means of a single, daily intramuscular injection of the hormone in oil or by the subcutaneous implantation of pellets of crystalline hormone at intervals of 12 to 14 months. Furthermore, most patients can afford the cost of synthetic hormone therapy. Limiting factors in the exclusive use of desoxycorticosterone therapy are its deficiency in the ‘carbohydrate regulating factor’ of the adrenal cortex and the care which must be exercised in the administration of this preparation in order to prevent the occurrence of overdosage phenomena (1). Methods of administering desoxycorticosterone acetate, other than by intramuscular injection of hormone in oil or subcutaneous implantation of pellets have been attempted (2, 3). These methods have had as their aim the elimination of the necessity for daily injections of hormone in oil or for surgical implantation of pellets.
No takes yet. Share an insight, caveat, or question.
Thorn et al. (1941) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: